Literature DB >> 15708931

Classification and diagnostic criteria for psoriatic arthritis.

P S Helliwell1, W J Taylor.   

Abstract

BACKGROUND: The study of psoriatic arthritis is difficult and has lagged behind the study of other arthropathies in that there are no universally agreed or properly validated case definitions.
METHOD: This paper examined the validity and practicality of the original Moll and Wright criteria and subsequent criteria sets. Key features discriminating between psoriatic and other arthropathies were reviewed. A comparative study involving patients with psoriatic arthritis and rheumatoid arthritis was used to contrast the different classification methods.
RESULTS: Although the Moll and Wright criteria continue to be widely used, they have been shown to discriminate poorly between psoriatic and rheumatoid arthritis. In comparison, the most sensitive criteria were those of Vasey and Espinoza, McGonagle et al, and Gladman et al (99%), whereas the others were significantly less sensitive (between 56% and 94%). The specificity of all methods was high and statistically similar (between 93% and 99%). Models that had reasonably good accuracy even without such key variables as psoriasis or rheumatoid factor were developed. Spinal involvement continues to be a key feature of psoriatic arthritis, but dissimilarities with classic ankylosing spondylitis have been highlighted.
CONCLUSIONS: Further work is required to produce classification criteria for psoriatic arthritis. A prospective study collecting clinical, radiological, human leucocyte antigen (HLA) and immunological data from both psoriatic and non-psoriatic cases should provide agreed criteria for use in psoriatic arthritis studies in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708931      PMCID: PMC1766878          DOI: 10.1136/ard.2004.032318

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

Review 1.  Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis.

Authors:  C Palazzi; I Olivieri; A Petricca; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  2002 Jan-Feb       Impact factor: 4.473

2.  Psoriasis and arthritis.

Authors:  V WRIGHT
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

3.  Latent variable modeling of diagnostic accuracy.

Authors:  I Yang; M P Becker
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

4.  Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.

Authors:  N Bizzaro; G Mazzanti; E Tonutti; D Villalta; R Tozzoli
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

5.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.

Authors:  B Fournié; L Crognier; C Arnaud; L Zabraniecki; V Lascaux-Lefebvre; V Marc; E Ginesty; V Andrieu; C Dromer; A Fournié
Journal:  Rev Rhum Engl Ed       Date:  1999-10

6.  Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report.

Authors:  C Biondi Oriente; R Scarpa; A Pucino; P Oriente
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

7.  Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model.

Authors:  P S Helliwell; J Hetthen; K Sokoll; M Green; A Marchesoni; E Lubrano; D Veale; P Emery
Journal:  Arthritis Rheum       Date:  2000-04

8.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

9.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

Review 10.  A review of the epidemiology of psoriasis vulgaris in the community.

Authors:  A Plunkett; R Marks
Journal:  Australas J Dermatol       Date:  1998-11       Impact factor: 2.875

View more
  65 in total

1.  Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study.

Authors:  Dalila Mrabet; Lilia Laadhar; Héla Sahli; Béchir Zouari; Slim Haouet; Sondès Makni; Slaheddine Sellami
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  [Psoriasis arthritis. An interdisciplinary challenge].

Authors:  M A Radtke; K Reich; F Beikert; M Augustin
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

3.  Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need.

Authors:  Alexis Ogdie; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-07

Review 4.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

Review 5.  Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

6.  Ectopic lymphoid neogenesis in psoriatic arthritis.

Authors:  Juan D Cañete; Begoña Santiago; Tineke Cantaert; Raimon Sanmartí; Antonio Palacin; Raquel Celis; Eduard Graell; Beatriz Gil-Torregrosa; Dominique Baeten; José L Pablos
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

7.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

8.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-03-04       Impact factor: 2.631

9.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-09-03       Impact factor: 2.631

10.  Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Authors:  N Inanc; E Dalkilic; S Kamali; E Kasapoglu-Günal; Y Elbir; H Direskeneli; M Inanc
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.